Author: Beghou Consulting

Beghou Consulting’s new cloud-based forecasting platform, Mainsail™ Forecast, was named one of the most innovative products of 2020 by PM360 Magazine. The platform allows life sciences companies to perform complex calculations related to treatment regimens, patient flows, lines of therapy and more, resulting in a more robust, accurate forecast. Read more in PM360 magazine.

Patient compliance has become a more acute challenge during the coronavirus pandemic. In this article in Pharmaceutical Executive, Beghou Consulting Partner Dan Wetherill explains how biopharmaceutical companies can play a significant role in improving patient compliance by leveraging their advanced analytics capabilities and increasing collaboration with caregivers.

The coronavirus pandemic has limited patient visits to health care providers, interfered with treatment schedules and slowed down disease diagnoses. Vice President Janardhan Vellore explains in Pharmaceutical Commerce how biopharmaceutical companies can rethink their go-to-market strategies to reach patients and physicians using virtual selling and non-personal promotional tactics.

Life sciences companies are faced with overwhelming amounts of data. As they seek to organize, manage and extract insights from this data, a cross-functional team can help better execute data strategy, ensure compliance and meet analytics goals. Associate Partner Piotr Kula describes in PM360 how to address this data overload.

The coronavirus pandemic has drastically changed the way patients prefer to receive health care – from virtual appointments to delayed treatments. Vice President Janardhan Vellore outlines in Pharmaceutical Executive how biopharmaceutical companies can reinvent the hub to improve patient access and engagement.

The brand story is an essential component of product launch, informing everything from go-to-market strategy to color schemes and logos. It can also successfully position a product in a competitive marketplace. Manager Esin Izat, leader of our marketing research practice, describes in PharmaVOICE how to use marketing research to craft compelling brand stories.

While pharmaceutical commercial teams navigating the COVID-19 pandemic don’t face the same life-or-death decisions the Apollo 13 team did 50 years ago, they are still responding to rapidly evolving circumstances in an uncertain environment. In Med Ad News, Partner Jon Hesby and Associate Partners Kevin Frymire and Rob Lien share three lessons from the Apollo 13 story that can help pharma companies today.